Global Biobank Management Systems Market Growth (Status and Outlook) 2025-2031

The global Biobank Management Systems market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of % from 2025 to 2031.

Biobank Management System is a sample library resource management system based on cell sample workflow. According to the operations involved in the laboratory sample workflow, the entire process recording of the sample life cycle and efficient and continuous management of all-round quality control are achieved.

Biobanks are becoming increasingly important to many organizations in the biotechnology, pharmaceutical industries, and medical research fields as there is a growing awareness of their ability to answer relevant research questions. The higher the quality of biobanks, the more accurate or fine-grained the research based on them will be. This requires excellent management of various samples such as blood, tissue, saliva, DNA, etc., integration with electronic medical/health records (EMR/EHR), and compliance with relevant regulatory environments such as HTA, GCLP, MHRA, FDA 21 CFR Part 11 and other similar requirements. Real-time complete sample inventory is critical, including tracking aliquots, pooled samples, and samples processed for experiments and subsequently stored. Other requirements often include logistics management and cold chain monitoring.

ReportPrime' newest research report, the “Biobank Management Systems Industry Forecast” looks at past sales and reviews total world Biobank Management Systems sales in 2024, providing a comprehensive analysis by region and market sector of projected Biobank Management Systems sales for 2025 through 2031.

With Biobank Management Systems sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biobank Management Systems industry.

This Insight Report provides a comprehensive analysis of the global Biobank Management Systems landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Biobank Management Systems portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Biobank Management Systems market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biobank Management Systems and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity.

With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biobank Management Systems.

This report presents a comprehensive overview, market shares, and growth opportunities of Biobank Management Systems market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Cloud
• On-Premises

Segmentation by Application:

• Medical
• Pharmaceutical
• Laboratory
• CRO
• Others

Market by Region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

Company’s Coverage:

• Thermo Fisher Scientific
• Agilent Technologies
• Autoscribe Informatics
• DiData
• AgileBio
• CloudLIMS
• Modul-Bio
• TD Biobank
• OpenSpecimen
• Information Management Services
• Azenta
• BBMS
• LabKey
• FreeLIMS
• LabWare
• Titian
• Octalsoft
• Interactive Software
• eLabNext
• SoftSystem
• STARLIMS
• NEST
• Origincell
• Improve Medical

Key Questions Addressed in this Report: